Further, the role of EGFR in NRP1-induced PCa progression was evaluated by using gefitinib, a specific inhibitor of EGFR, in NRP1-overexpressed PCa cells to ascertain the changes in cell proliferation and migration. The gene discussed is NRP1; the disease is posterior cortical atrophy.